New Strategies for HIV Prevention in Africa: Envisioning the End of AIDS

Start Date and Time
End Date and Time

Location:  Room T-733, UW Health Sciences Building

Televised at the following locations:

  • Harborview Medical Center, Ninth and Jefferson Building (NJB) - 1360
  • Seattle Children's Research Institute - Pearl Jam Room 806
  • Washington State University - Riverpoint Campus, Spokane Academic Center (SAC) - Room 515
  • University of Alaska - Anchorage - CPISB 101-D; Fairbanks - 210 West Ridge Research Building

Dr. Baeten received his PhD in Epidemiology and his MD from the University of Washington.  His research focuses on epidemiologic studies of HIV and other sexually transmitted infections and clinical trials of novel HIV prevention interventions.  Dr. Baeten has worked on studies of HIV prevention in Africa for more than 15 years.  He co-chairs the Partners PrEP Study, which recently demonstrated that using anti-HIV medications as pre-exposure prophylaxis (PrEP) provided 75% protection against heterosexual HIV acquisition.  The results from that study served as the basis for the first approval by the U.S. Food and Drug Administration of a medication for preventing HIV acquisition.

For more information, contact